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Abstract:  While autophagy has been shown to act as an anti-viral defense, the 
Picornaviridae avoid and, in many cases, subvert this pathway to promote their own 
replication. Evidence indicates that some picornaviruses hijack autophagy in order to 
induce autophagosome-like membrane structures for genomic RNA replication. Expression 
of picornavirus proteins can specifically induce the machinery of autophagy, although the 
mechanisms by which the viruses employ autophagy appear to differ. Many picornaviruses 
up-regulate autophagy in order to promote viral replication while some members of 
the  family also inhibit degradation by autolysosomes. Here we explore the unusual 
relationship of this medically important family of viruses with a degradative mechanism of 
innate immunity. 
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1. Introduction  
Autophagy is a cellular process by which cytosolic material is targeted for degradation by the 
cell [1]. Autophagy initiates when proteins, membranes, and organelles are engulfed into a unique 
double-membraned structure known as an autophagosome. This vesicle matures by acidification and 
fuses with lysosomes to form the degradative autolysosome [2]. Autophagy plays important roles in 
breaking down protein aggregates and cellular structures as well as recycling of intracellular 
components [3]. In addition to maintaining cellular homeostasis, autophagy can be induced by cellular 
stressors such as starvation, drug treatments, or infection. Autophagy is also as a mechanism by which 
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the cell controls infection through degradation of cytosolic viruses and bacteria [4,5]. However, as is 
true for most immune responses, several pathogens subvert the autophagic machinery in order to 
promote their survival and replication. 
In retrospect, the history of picornaviruses and autophagosomes stretches back to some of the 
earliest fine-detailed microscopic analyses of infected cells. For years, scientists have been learning 
how this medically important class of viruses rearranges cellular ultrastructure. In 1958, the first 
electron microscopy (EM) analysis was carried out by Marguerite Vogt’s group, using monkey kidney 
cells infected with poliovirus (PV) [6]. This study, one of the first EM studies conducted on a 
uniformly infected, synchronous population of infected cells, identified cytoplasmic vesicles termed by 
the authors “U bodies”. The presence of U bodies correlated with the maximal release of virus from 
the cells. As lysis approached, clear vacuoles were seen in place of the U bodies. The techniques used 
were insufficient to identify virions during infection. However, this work clearly established the 
unusual pattern of membrane rearrangements in the cytoplasm of picornavirus-infected cells. 
In 1962, Samuel Dales and Richard Franklin published a fine structure study of murine L cells 
infected with encephalomyocarditis virus (EMCV) [7]. The images demonstrate cytoplasmic regions 
filled with multi-lamellar structures, which we would now identify as autophagosomes. This study 
marks the first demonstration that we can find of autophagic induction in a picornavirus-infected cell. 
Although large crystalline arrays of virus are observed in the cytoplasm, it is difficult to tell if any are 
within the membrane-bound cytoplasmic bodies. 
In 1965, Dales, working with George Palade, published a comprehensive EM analysis of 
PV-infected cells [8]. The authors analyzed HeLa cells treated with PV at a high multiplicity of 
infection (MOI  = 22) and used EM protocols that provided high-contrast images of intracellular 
membranes. In their images, Dales and Palade identified “membrane-enclosed cell bodies” occupying 
nearly the entire cytoplasm of the cell. They identified these bodies, which they measured to   
be 70–200 nm each in diameter, to be the same as the U bodies observed by Vogt. In the Dales study, 
progeny virus particles were observed both inside and outside the small bodies. These vesicles clearly 
have two lipid bilayers with an electron-light luminal region in between, a hallmark of classical 
autophagosomes. The authors suggested that newly formed viral particles were being taken up into 
these vesicles as a response to infection. 
The question remained whether such vesicles are present or relevant during infections in vivo. It 
was not until 1984 that the neurons of PV-infected monkeys were examined at the level of electron 
microscopy [9]. The double-membraned vesicles seen in this in vivo study bear a strong resemblance 
to the vesicles identified by Dales and Palade in HeLa cells, and are strikingly similar to 
autophagosomes. This same study found double-membraned vesicles in PV-infected cultured 
cynomolgus monkey kidney (CMK) cells, indicating that the membrane rearrangements in cultured 
cells reflect in vivo intracellular rearrangements. Therefore, these membranes have been the subject of 
intense study for years. 
Although the molecular tools to conclusively identify these membranes as autophagosomes would 
not be available for years, the evidence for double-membraned vesicle formation during picornavirus 
infection has been accumulating for more than half a century. Many questions remained—first and 
foremost being what role these vesicles play in the virus life cycle and the interaction between the 
virus and its host. Viruses 2011, 3 
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2. Membranes and Picornavirus RNA Replication 
The predominant hypothesis for the role of autophagosomes in the viral life cycle is that they serve 
as a physical substrate for viral genomic RNA replication. All positive-sense RNA viruses replicate 
their RNA in association with cellular membranes, as has been extensively reviewed elsewhere [10]. 
The reason for this membrane association is unclear. The structure of the membrane-associated 
replication complexes varies from virus to virus, and it does not appear that the cellular origin of the 
membrane is important for RNA replication [11]. In fact, in at least one instance, retargeting the 
replication complex to a different cellular membrane seemed to promote increased RNA replication [12]. 
The majority of studies involving positive-strand RNA virus membrane rearrangements have 
focused on their putative association with RNA replication complexes. The nature of the membranes 
associated with viral RNA replication complexes differs among virus families and even among viruses 
within that family. Several flaviviruses, such as hepatitis C virus (HCV), use a “membranous web”, or 
“convoluted membrane”, as the site of RNA replication [13]. Severe acute respiratory syndrome 
(SARS) coronavirus replicates on a reticulovesicular network of membranes, including endoplasmic 
reticulum (ER)-derived vesicles [14,15]. For Semliki Forest virus, an alphavirus, replication 
complexes are found on modified lysosomes [16]. The nodavirus flock house virus replicates its 
genome on invaginations in the mitochondrial membrane [17]. 
For picornaviruses, the origin of the replication-associated membrane is not yet fully understood. 
There have been, to date, three hypotheses proposed for the membrane origin of picornavirus 
replication-associated membranes. One hypothesis, from studies of PV, suggests that vesicles 
resembling COPII secretory vesicles, which can be found in the cytoplasm following infection by PV, 
are the sites of RNA replication. These vesicles are marked with the COPII proteins Sec13 and Sec31 
as well as the Arf1 GTPase complex, which regulates secretory transport [18,19]. In published images, 
these appear to be distinct from the double-membraned vesicles first seen by Dales and replicated in 
many subsequent studies, so the COPII-like vesicles may represent a separate class of membrane 
induced during infection [8]. 
The second hypothesis is that RNA replication takes place on small vesicles containing trans-Golgi 
markers, as observed for human parechovirus, Theiler’s murine encephalomyelitis virus, and one strain 
of human rhinovirus (HRV), HRV-1A [20–23]. It is presumed that these small vesicles derive from 
breakup of the Golgi apparatus during infection, and as yet there has been no follow-up work to 
elucidate the mechanism of their formation. There may be overlap between these vesicles and the 
COPII vesicles observed during PV infection. 
The third hypothesis is that viral RNA replication takes place on double-membraned vesicles 
derived from the autophagy pathway (Figure 1). These vesicles contain autophagy marker proteins as 
well as virus replication proteins. Since the autophagy pathway was found to promote PV replication, 
autophagosomes have been identified during infection by several other picornaviruses, including 
foot-and-mouth disease virus (FMDV), enterovirus 71 (EV71), EMCV, HRV, and coxsackieviruses. 
The data regarding autophagy during infection by each of these viruses is discussed in the 
next sections. 
It is important to note that the three hypotheses for the origin of picornavirus RNA replication 
membranes are not mutually exclusive. HRV-1A, for example, does not induce autophagic signaling or Viruses 2011, 3 
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autophagosomes [21]. This indicates that from virus to virus there is variation in the membrane-
generating pathways induced, and that there is no universal picornavirus replication membrane. It is 
possible that autophagosomes contain Sec13, Sec31, and Arf1, unifying the two classes of vesicle seen 
during PV infection. It is also possible that there are two distinct classes of vesicle during infection, a 
COPII-derived vesicle and a vesicle derived from the autophagy machinery, each with distinct roles 
and identities. The remainder of this review focuses on the known connections between autophagy and 
picornavirus replication. 
3. Poliovirus Subversion of the Autophagic Machinery 
In order to understand the nature and origin of the observed vesicles, immuno-EM experiments 
were performed on PV-infected HeLa cells [24]. Initial experiments suggested that PV induced 
double-membraned autophagic-like structures 50–500 nm in diameter. While this is consistent with 
previous work, these structures are smaller than typical autophagosomes, which range from 500–1500 nm 
in diameter [8,25]. Using an antibody to the viral protein 2C to identify PV-relevant vesicles, cellular 
fractionation studies showed that these vesicles co-sediment with a variety of markers for ER, Golgi, 
and lysosomes [24,26]. Since autophagosomes contain markers from throughout the cell, these data led 
to the hypothesis that autophagy is involved in the formation of PV-induced membranes.  
Confirmation of the nature of these vesicles had to wait for the identification of specific markers to 
monitor autophagosome formation, maturation and degradation. Genetic studies of the yeast 
Saccharomyces cerevisiae identified several genes, now termed ATG genes, essential for the 
autophagic pathway. Many of these genes are conserved in mammalian systems [27]. Although the 
signals leading to autophagic induction are still poorly understood, these studies have provided cellular 
protein markers for autophagosomal membranes and autophagic degradation, as shown in Figure 1. 
Microtubule-associated protein light chain 3 (LC3), the mammalian homolog of yeast ATG8p, is a 
specific marker of autophagic membranes. LC3 is found in the cytoplasm when autophagy levels are 
low; this form is known as LC3-I. However, upon induction of autophagy LC3-I is conjugated to 
phosphatidylethanolamine (PE) and thereafter becomes membrane-bound to autophagosomes; this 
form is known as LC3-II (Figure 1, part 3) [28]. LC3-II appears to be required to complete formation 
of the autophagosome [29]. The isoforms of LC3 can be distinguished by Western blotting and a 
relative increase in LC3-II levels is indicative of increased autophagy. In addition, LC3 conjugated to 
GFP can be expressed in cells and monitored by immunofluorescence; LC3-GFP will form puncta in 
response to induction of autophagy. The ubiquitin-binding protein p62 also interacts with LC3-II in 
order to target cargo to autophagosomes for degradation [30]. Since p62 is degraded along with the 
rest of the autophagosome contents, steady-state levels of p62 can be monitored as an indicator of 
autophagic degradation levels. Advances in technology also allowed for the manipulation of the 
autophagic pathway via gene knockdown of various ATG proteins, the effects of which could be 
assessed by these newly available assays. 
Using LC3 as a marker, studies were undertaken to investigate the PV-induced vesicles [31]. When 
GFP-LC3 was expressed in MCF-7 human breast cancer cells during PV infection, the GFP   
signal co-localized with the viral 3A protein, a component of viral replication complexes on host 
membranes [32]. Immunofluorescence showed that inducing autophagy using the pharmacological Viruses 2011, 3 
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inducers rapamycin or tamoxifen when GFP-LC3 was expressed induced puncta indicative of 
autophagy.  
Figure 1. A simplified model of autophagy. 1. The mTOR complex mTORC1 acts 
upstream of the autophagic pathway to suppress autophagic membrane formation, and 
mTOR activity can be monitored by detecting the activation of its downstream target S6 
kinase. mTORC1 is inhibited when autophagy is induced via a cellular stress such as 
starvation or a drug treatment like rapamycin. 2. After initiation of autophagy, a complex 
containing the Atg protein Beclin-1 is necessary for autophagosome formation. Tamoxifen 
induces autophagy by indirectly acting upon Beclin-1, while 3-MA suppresses autophagy 
due to its inhibition of PI3 kinases that interact with Beclin-1. The picornaviruses PV, 
CVB3, HRV-2, HRV-14, EV71, FMDV and EMCV have been shown to induce 
autophagic membrane formation. 3. During autophagic membrane formation, the cytosolic 
Atg protein LC3-I becomes conjugated to PE, mediated in part by the ubiquitin E1-like 
enzyme Atg7, to form LC3-II. LC3-II proteins then specifically associate with a 
newly-formed crescent-shaped membrane termed a phagophore. The conversion of LC3-I 
to LC3-II has been observed with all of the picornaviruses discussed at length in this 
review.  4. The phagophore elongates around cytosolic contents until the contents are 
completely sequestered within a fully formed double-membraned autophagosome. The 
formation of the autophagosome requires the ubiquitin-like protein Atg12. 5. The 
autophagosome matures, becoming acidic, and fuses with lysosomes to form the 
degradative autolysosome. The cytosolic contents are degraded, and LC3-II is also 
degraded or recycled back to LC3-I. CVB3 appears to block this degradative step, while 
EMCV does not. 
 Viruses 2011, 3 
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During infection, punctate LC3 also co-localized with lysosomal-associated membrane protein 
LAMP1, a marker of late endosomes and lysosomes [31]. Studies of Legionella pneumophila had 
previously established co-localization of punctate LC3 with LAMP1 as an assay for identifying mature 
autophagosomes [33]. These data suggested that autophagosomes were forming and perhaps maturing 
in the presence of PV. When the viral proteins 2BC or 3A were individually expressed in human 
embryonic kidney (HEK) 293T cells, this co-localization was not observed. Only when the two 
proteins were co-expressed did LAMP1 co-localize with GFP-LC3. 
When rapamycin or tamoxifen were present during infection of H1-HeLa cells the intracellular 
production of PV increased [31]. However, the autophagy inhibitor drug 3-MA decreased viral yield. 
In addition, RNAi directed against LC3 or ATG12 reduced both intracellular and extracellular viral 
titers. This study provided the first evidence that PV subverts the autophagic pathway in order to 
generate membranes for establishing viral replication complexes. The effect of inhibiting autophagy 
was more pronounced on levels of virus found in the medium prior to cell lysis than on cell-associated 
virus. Therefore, these data provided the first indication that the autophagy pathway plays a role in 
extracellular release of cytosolic contents. The existence of a non-conventional secretory pathway 
regulated by autophagy has now been confirmed using several other assays [34–36]. 
4. The Role of Autophagy during Infection by Other Picornaviruses 
PV was the first picornavirus shown to subvert the autophagic machinery to promote its own 
replication, and several other picornaviruses have since been described to have a similar relationship 
with the autophagy pathway. Coxsackievirus group B (CVB), the most common cause of viral 
myocarditis, has also been reported to perturb the autophagic pathway in order to replicate on the 
surface of autophagosomes [37]. Ultrastructural analysis revealed that double-membraned vesicles 
were induced in HeLa or HEK 293T cells during infection with CVB3. Correspondingly, levels of 
LC3-II were significantly increased during infection. The GFP-LC3 signal re-localized to puncta in the 
presence of CVB3 as well, indicating that CVB3 infection induces autophagosome formation. Both 
viral titer and expression of the capsid protein VP1 decreased in the presence of 3-MA. Conversely, 
rapamycin treatment enhanced viral titer, and VP1 levels increased under starvation conditions. In 
addition, both VP1 expression and viral titer were reduced when the autophagy proteins Beclin-1, 
ATG7, and Vps34 were knocked down. The phosphorylation of eIF2α has been shown to be required 
for induction of autophagy; accordingly, the levels of phosphorylated eIF2α increased during viral 
infection [37,38]. However, p62 levels were not affected by CVB3 infection, indicating that 
degradation of autophagic targets was blocked. Furthermore, inhibition of the lysosome by LAMP-2 
knockdown resulted in an increase in both VP1 levels and viral production. Taken together, this work 
suggests that CVB3 induces autophagic signaling to promote viral replication, but prevents 
autolysosome formation and autophagic degradation. 
This research was extended in vivo using GFP-LC3 transgenic mice [39]. The murine pancreas was 
investigated because CVB3 reaches high viral load in this organ. When mice were infected with 
CVB3, the levels of LC3-II continually increased in the pancreas during the time course examined. 
The levels of p62 also built up over time, indicating that degradation was inhibited. In addition, 
GFP-LC3 re-localized to puncta that did not co-localize with LAMP1, suggesting that autophagic flux Viruses 2011, 3 
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was blocked. Further observation revealed that, compared to uninfected controls, infected cells 
contained large GFP-LC3 positive structures. In addition, smaller vesicles were observed, leading the 
authors to distinguish between autophagosomes and the large structures, which were termed 
megaphagosomes. Ultrastructural analysis on CVB3-infected cells showed an abundance of small 
(~250 nm) autophagosome-like vesicles similar to those observed during PV infection as well as more 
typically sized autophagosomes. Some megaphagosomes (2–3 μm) were also detected and appeared to 
have double membranes. Immuno-EM confirmed that LC3 was localized to the megaphagosome 
membrane. This work is consistent with the in vitro research in that CVB3 infection appears to induce 
autophagy and block autolysosome formation. However, more studies will need to be performed to 
investigate the link between viral induction of autophagy and viral replication in vivo. 
CVB4 infection, tested in primary rat neurons, has been reported to have a similar relationship to 
autophagy as CVB3 [40]. LC3 was modified during infection and both autophagosome formation and 
viral production were suppressed in the presence of 3-MA. Calpain, a calcium-dependent cysteine 
protease, was also investigated for its role in CBV4-induced autophagy. Cleavage of spectrin, a calpain 
substrate, increased during viral infection and was inhibited in the presence of 3-MA. Calpain 
inhibitors caused a decrease in VP1 expression and viral production. Autophagosome formation was 
also depressed when infected cells were treated with the calpain inhibitors. This work demonstrated a 
role for calpain in CVB4-induced autophagy. 
HRV, a major cause of the common cold, also frequently plays a role in asthma development and 
exacerbation. The species is divided into major and minor serotype groups, depending on the receptor 
utilized for cellular entry. HRV-14, a major group virus, and HRV-2, a minor group virus, have been 
shown to induce autophagy [31]. As with PV, infection with either HRV-2 or HRV-14 caused a 
co-localization of LAMP1 with punctate GFP-LC3 in MCF-7 cells. Further, monodansylcadaverine, a 
fluorophore retained in autophagosomes under gentle cell fixation conditions, showed a punctate 
pattern after infection with HRV14 that appeared similar to that observed during tamoxifen treatment. 
Finally, HRV-14 induced the formation of autophagosome-like vesicles. These data suggest that the 
HRVs examined induce autophagy. The effect of autophagy on HRV-2 replication is somewhat 
controversial, as a subsequent paper proposed that induction of autophagy did not affect HRV-2 viral 
production [41]. However, recent work showed that HRV-2 induces and subverts the autophagic 
pathway in order to promote viral replication [42]. Formation of GFP-LC3 puncta was observed 
following infection of HEK 293T cells with HRV-2. Further, modification of LC3 was detected during 
infection using Western blotting. Finally, induction of autophagy with rapamycin resulted in an 
increase in HRV-2 titers similar to that seen with PV, and a corresponding decrease was detected when 
autophagy was inhibited using 3-MA. This study confirmed the initial report that HRV-2 induces the 
autophagic pathway during infection and extended these findings to show that HRV-2 responds to the 
autophagic pathway in a manner similar to that of PV. 
EV71 is one of the causative agents of hand-foot-and-mouth disease and is associated with 
neurological diseases in young children. One report provides evidence that EV71 induces autophagy 
that is associated with viral replication [43]. Upon infection with EV71, muscle or neuronal cell lines 
transfected with GFP-LC3 showed puncta formation indicative of autophagy, and EM analysis 
detected autophagosome-like vesicles of 100–500 nm in diameter in the presence of EV71. LC3-II 
levels also increased via Western blotting. Viral titers decreased in the presence of 3-MA and Viruses 2011, 3 
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increased in the presence of inducers of autophagy, indicating that autophagy enhanced viral 
production. Furthermore, phosphorylation of both mTOR, a major effector of autophagic signaling, 
and its downstream target S6 kinase decreased during viral infection. Finally, experiments showed that 
mice infected with EV71 developed double-membraned structures in their cervical spinal cord 
neurons. By immuno-EM analysis, LC3 and the viral protein VP1 co-localized with these structures. 
Taken together, these data suggest that EV71 induces autophagy both in vitro and in vivo to facilitate 
viral replication, likely in a manner similar to that seen with PV infection. 
FMDV, a highly infectious and contagious agricultural pathogen, has also been shown to exploit 
autophagy for viral replication [44]. During FMDV infection, GFP-LC3 signal re-localized from 
throughout the cytoplasm to the perinuclear region and co-localized with viral nonstructural proteins. 
The viral capsid protein VP1 co-localized with both GFP-LC3 puncta as well as the autophagy protein 
ATG5, which also appears to be in a punctate distribution during infection. Further, only during 
rapamycin treatment or FMDV infection did punctate GFP-LC3 co-localize with LAMP1. As seen 
with other picornaviruses, induction of autophagy using rapamycin enhanced viral production, whereas 
3-MA treatment caused a reduction in viral production. Silencing either LC3 or ATG5 via siRNA also 
caused both intracellular and extracellular viral yield to be suppressed. Lastly, EM showed that 
formation of both single-membraned and double-membraned structures approximately 150 nm in 
diameter increased during FMDV infection; these structures co-localized with LC3 as well as the viral 
protein 2B. These results suggest that FMDV, like the previously discussed picornaviruses, induces the 
formation of autophagosome-like vesicles in order to enhance virus production. 
EMCV, an agent of acute viral myocarditis, infects a wide range of hosts from rodents to humans 
but is particularly fatal in pigs. Recently published work details the role of autophagy in EMCV 
infection [45]. Utilizing a variety of rodent cell lines, EM showed that the number of autophagosome-
like vesicles significantly increased during infection as compared to uninfected cells. LC3-II levels 
also increased upon infection, paralleling the EM results. The authors used UV-treated virus to show 
that active virus was required in order to generate the increase in LC3-II. Expression of GFP-LC3 
re-localized from diffuse cytosolic staining to distinct puncta in the presence of the virus, and these 
puncta co-localized with the viral capsid protein VP1. The authors also observed a decrease in 
steady-state levels of p62 during EMCV infection. Treatment of the cells with E64-d, an inhibitor of 
cysteine proteases found in lysosomes, caused a rise in the levels of p62 as well as LC3, suggesting 
that EMCV was promoting autophagic degradation.  
Treatment with rapamycin yielded significant increases in both intracellular and extracellular 
EMCV titers, and 3-MA treatment led to a loss in LC3 modification as well as a loss in GFP-LC3 
puncta formation [45]. However, these treatments did not affect viral uptake or cell viability. siRNAs 
against either LC3 or ATG7 resulted in a reduction in intracellular and extracellular viral yields as well 
as a decrease in the levels of VP1 protein detected via Western. This work indicates that autophagy 
promotes EMCV replication. However, the mechanism may differ between PV and coxsackieviruses, 
as the replication of these viruses suffer in the presence of brefeldin A. 
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5. The Roles of Specific Viral Proteins in Induction of Autophagic Signaling 
Most of what is known about the virus proteins involved in induction and regulation of autophagy 
comes from studies of PV. The contiguous region of the viral genome spanning the proteins 2B, 2C, 
and 3A is involved in altering the physical structure of the cell during virus replication. Previous 
studies have shown that expression of the viral protein 3A leads to severe swelling of the ER due to 
inhibition of the ER-Golgi trafficking, while the 2C protein plays a role in host membrane 
rearrangements and viral replication [46–48]. The 2C protein did not co-fractionate with the ER 
marker p63. When 3A was expressed singly or co-expressed with 2C, the ER marker calnexin did 
co-fractionate with these viral proteins [26]. It is possible that some host proteins may be excluded 
from these membranes due to modification by the viral proteins, but more research needs to be 
performed to investigate this phenomenon.  
Expression of the viral precursor protein 2BC yielded single-membraned electron-light vesicles, in 
contrast to those induced by infection with PV [26]. Co-expression of 2BC and 3A not only showed 
membranes of a similar density to those induced by PV, but those membranes appeared to be 
autophagosome-like as well. This work not only provided a new method for examining 
autophagosomes, but identified the specific viral proteins that play a role in inducing autophagosome-
like vesicles. 
In addition to generating single-membraned vesicles, 2BC is sufficient to induce lipidation of 
cytosolic LC3-I to generate membrane-associated LC3-II [26,48]. Interestingly, expression of either 
2B or 2C alone was not sufficient to increase LC3-II levels, indicating that a function of the 2BC 
precursor is required for this effect [49]. 2BC was among the first proteins identified shown to be 
sufficient for induction of autophagic signaling. This makes it all the more curious that classical 
double-membraned autophagosomes are not observed when 2BC is expressed alone. These data 
indicated for the first time that LC3-II formation is not sufficient for autophagosome formation. The 
specific role of 3A in forming autophagosomes is not yet understood. 
Little is known about the proteins of other picornaviruses and their roles in inducing or regulating 
autophagy. When expressed in the absence of other viral proteins, the EMCV and FMDV 3A proteins 
each co-localize with GFP-LC3 [43,44]. These results are similar to those seen with PV 3A [31]. It has 
been shown that co-expression of FMDV 2B and 2C is sufficient to recapitulate certain functions of 
2BC, but this is not the case for co-expression of PV 2B and 2C [49,50]. Therefore, the role of 2BC 
and its cleavage products may differ between FMDV and PV. It is unclear if the 2BC and 3A proteins 
of HRV-14 and CVB3 exhibit analogous functions during infection. More research is needed to fully 
understand how the picornaviruses utilize these proteins, perhaps in different ways, in order to induce 
and regulate autophagy. 
6. The Purpose of Autophagy in the Picornavirus Life Cycle 
The relationship between picornaviruses and autophagy appears to be unique among virus families. 
No other virus family has been consistently shown to subvert the autophagy pathway. Although some 
individual family members appear indifferent to autophagy, it is clear that the ability to subvert Viruses 2011, 3 
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autophagy is shared by a large number of picornaviruses [21,41]. This suggests a common mechanism 
used by most species of the picornavirus family. 
The specific role of autophagy in picornavirus replication remains a mystery. The presumption has 
been that the pathway plays an important role in generating membrane substrates for viral RNA 
replication. This remains to be formally demonstrated. In the case of PV, it remains to be seen whether 
the autophagosome-like and COPII-like vesicles identified by different groups are the same or unique, 
and whether they have separate or overlapping roles in promoting PV replication [8,18]. 
Coxsackievirus has been shown to inhibit autophagic degradation in a manner reminiscent of 
L. pneumophila [33,37,39]. This makes sense, as one can imagine the advantage to blocking 
degradation of nascent virions. However, during EMCV infection autophagic degradation increases, 
yet increasing autophagic signals still promotes production of infectious virus [45]. It is possible that 
autophagy is performing fundamentally different roles in the life cycles of coxsackievirus and EMCV. 
Alternatively, EMCV may have evolved a different mechanism to avoid degradation of infectious 
virus. It remains to be seen whether promoting or inhibiting autophagic degradation will prove to be 
the rule among picornaviruses. 
The primary remaining question is, why autophagy? More specifically, what does this pathway 
uniquely provide to the Picornaviridae? There are several possibilities. The double-membraned nature 
of the vesicles is unique and may, for some reason, provide a superior substrate for viral RNA 
replication. Autophagosome membranes may contain proteins or lipids that promote genome 
production. The trafficking and localization of the autophagosome may be advantageous, either for 
RNA replication or a post-RNA step in producing infectious virus and delivering it to the extracellular 
space. Alternatively, there may be an advantage to subverting autophagy that we do not yet 
understand. The specific nature of the relationship between picornaviruses and autophagy will likely 
remain a focus of research for years to come. 
Acknowledgments 
The authors were supported by the Advancing a Healthier Wisconsin fund. 
Conflict of Interest 
The authors declare no conflict of interest.  
References and Notes 
1.  Yang, Z.; Klionsky, D.J. Eaten alive: A history of macroautophagy. Nat. Cell Biol. 2010, 12,  
814–822. 
2.  Deretic, V.; Levine, B. Autophagy, immunity, and microbial adaptations. Cell Host Microbe 
2009, 5, 527–549. 
3.  Levine, B.; Mizushima, N.; Virgin, H.W. Autophagy in immunity and inflammation. Nature 
2011, 469, 323–335. 
4.  Kudchodkar, S.B.; Levine, B. Viruses and Autophagy. Rev. Med. Virol. 2009, 19, 359–378. Viruses 2011, 3 
 
1559
5.  Deretic, V. Autophagy in immunity and cell-autonomous defense against intracellular microbes. 
Immunol. Rev. 2011, 240, 92–104. 
6.    Kallman, F.; Williams, R.C.; Dulbecco, R.; Vogt, M. Fine structure of changes produced in 
cultured cells sampled at specified intervals during a single growth cycle of polio virus. 
J. Biophys. Biochem. Cytol. 1958, 4, 301–308. 
7.   Dales, S.; Franklin, R.M. A comparison of the changes in fine structure of l cells during single 
cycles of viral multiplication, following their infection with the viruses of mengo and 
encephalomyocarditis. J. Cell Biol. 1962, 14, 281–302. 
8.   Dales, S.; Eggers, H.J.; Tamm, I.; Palade, G.E. Electron microscopic study of the formation of 
poliovirus. Virology 1965, 26, 379–389. 
9.    Hashimoto, I.; Hagiwara, A.; Komatsu, T. Ultrastructural studies on the pathogenesis of 
poliomyelitis in monkeys infected with poliovirus. Acta Neuropathol. 1984, 64, 53–60. 
10.    Salonen, A.; Ahola, T.; Kaariainen, L. Viral RNA replication in association with cellular 
membranes. Curr. Top. Microbiol. Immunol. 2005, 285, 139–173. 
11.  Mackenzie, J. Wrapping things up about virus RNA replication. Traffic 2005, 6, 967–977. 
12.   Miller, D.J.; Schwartz, M.D.; Dye, B.T.; Ahlquist, P. Engineered retargeting of viral RNA 
replication complexes to an alternative intracellular membrane. J. Virol. 2003, 77, 12193–12202. 
13.  Ferraris, P.; Blanchard, E.; Roingeard, P. Ultrastructural and biochemical analyses of hepatitis C 
virus-associated host cell membranes. J. Gen. Virol. 2010, 91, 2230–2237. 
14.  Knoops, K.; Kikkert, M.; Worm, S.H.; Zevenhoven-Dobbe, J.C.; van der Meer, Y.; Koster, A.J.; 
Mommaas, A.M.; Snijder, E.J. SARS-coronavirus replication is supported by a reticulovesicular 
network of modified endoplasmic reticulum. PLoS Biol. 2008, 6, e226. 
15.  Reggiori, F.; Monastyrska, I.; Verheije, M.H.; Cali, T.; Ulasli, M.; Bianchi, S.; Bernasconi, R.;  
de Haan, C.A.; Molinari, M. Coronaviruses hijack the LC3-I-positive EDEMosomes, ER-derived 
vesicles exporting short-lived ERAD regulators, for replication. Cell Host Microbe  2010, 7 ,  
500–508. 
16.  Spuul, P.; Balistreri, G.; Kaariainen, L.; Ahola, T. Phosphatidylinositol 3-Kinase-, Actin-, and 
Microtubule-dependent transport of semliki forest virus replication complexes from the plasma 
membrane to modified lysosomes. J. Virol. 2010, 84, 7543–7557. 
17.  Kopek, B.G.; Perkins, G.; Miller, D.J.; Ellisman, M.H.; Ahlquist, P. Three-dimensional analysis 
of a viral RNA replication complex reveals a virus-induced mini-organelle. PLoS Biol. 2007, 5, 
e220. 
18.  Rust, R.C.; Landmann, L.; Gosert, R.; Tang, B.L.; Hong, W.; Hauri, H.P.; Egger, D.; Bienz, K. 
Cellular COPII proteins are involved in production of the vesicles that form the poliovirus 
replication complex. J. Virol. 2001, 75, 9808–9818. 
19.    Belov, G.A.; Altan-Bonnet, N.; Kovtunovych, G.; Jackson, C.L.; Lippincott-Schwartz, J.; 
Ehrenfeld, E. Hijacking components of the cellular secretory pathway for replication of poliovirus 
RNA. J. Virol. 2007, 81, 558–567. 
20.  Krogerus, C.; Egger, D.; Samuilova, O.; Hyypia, T.; Bienz, K. Replication complex of human 
parechovirus 1. J. Virol. 2003, 77, 8512–8523. 
21.    Quiner, C.A.; Jackson, W.T. Fragmentation of the Golgi apparatus provides replication 
membranes for human rhinovirus 1A. Virology 2010, 407, 185–195. Viruses 2011, 3 
 
1560
22.  Krogerus, C.; Samuilova, O.; Poyry, T.; Jokitalo, E.; Hyypia, T. Intracellular localization and 
effects of individually expressed human parechovirus 1 non-structural proteins. J. Gen. Virol. 
2007, 88, 831–841. 
23.  Jauka, T.; Mutsvunguma, L.; Boshoff, A.; Edkins, A.L.; Knox, C. Localisation of Theiler's murine 
encephalomyelitis virus protein 2C to the golgi apparatus using antibodies generated against a 
peptide region. J. Virol. Methods 2010, 168, 162–169. 
24.  Schlegel, A.; Giddings, T.H., Jr; Ladinsky, M.S.; Kirkegaard, K. Cellular origin and ultrastructure 
of membranes induced during poliovirus infection. J. Virol. 1996, 70, 6576–6588. 
25.   Mizushima, N.; Ohsumi, Y.; Yoshimori, T. Autophagosome formation in mammalian cells. 
Cell Struct. Funct. 2002, 27, 421–429. 
26.   Suhy, D.A.; Giddings, T.H., Jr; Kirkegaard, K. Remodeling the endoplasmic reticulum by 
poliovirus infection and by individual viral proteins: An autophagy-like origin for virus-induced 
vesicles. J. Virol. 2000, 74, 8953–8965. 
27.   Tsukada, M.; Ohsumi, Y. Isolation and characterization of autophagy-defective mutants of 
saccharomyces cerevisiae. FEBS Lett. 1993, 333, 169–174. 
28.  Kabeya, Y.; Mizushima, N.; Ueno, T.; Yamamoto, A.; Kirisako, T.; Noda, T.; Kominami, E.; 
Ohsumi, Y.; Yoshimori, T. LC3, a mammalian homologue of yeast Apg8p, is localized in 
autophagosome membranes after processing. EMBO J. 2000, 19, 5720–5728. 
29.  Fujita, N.; Hayashi-Nishino, M.; Fukumoto, H.; Omori, H.; Yamamoto, A.; Noda, T.; Yoshimori, 
T. An Atg4B mutant hampers the lipidation of LC3 paralogues and causes defects in 
autophagosome closure. Mol. Biol. Cell 2008, 19, 4651–4659. 
30.  Pankiv, S.; Clausen, T.H.; Lamark, T.; Brech, A.; Bruun, J.A.; Outzen, H.; Overvatn, A.; Bjorkoy, 
G.; Johansen, T. P62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of 
ubiquitinated protein aggregates by autophagy. J. Biol. Chem. 2007, 282, 24131–24145. 
31.  Jackson, W.T.; Giddings, T.H., Jr; Taylor, M.P.; Mulinyawe, S.; Rabinovitch, M.; Kopito, R.R.; 
Kirkegaard, K. Subversion of cellular autophagosomal machinery by RNA viruses. PLoS Biol. 
2005, 3, e156. 
32.  Giachetti, C.; Hwang, S.S.; Semler, B.L. Cis-acting lesions targeted to the hydrophobic domain of 
a poliovirus membrane protein involved in RNA replication. J. Virol. 1992, 66, 6045–6057. 
33.  Swanson, M.S.; Isberg, R.R. Analysis of the intracellular fate of legionella pneumophila mutants. 
Ann. N. Y. Acad. Sci. 1996, 797, 8–18. 
34.   Manjithaya, R.; Subramani, S. Autophagy: A broad role in unconventional protein secretion? 
Trends Cell Biol. 2011, 21, 67–73. 
35.  Duran, J.M.; Anjard, C.; Stefan, C.; Loomis, W.F.; Malhotra, V. Unconventional secretion of 
Acb1 is mediated by autophagosomes. J. Cell Biol. 2010, 188, 527–536. 
36.   Manjithaya, R.; Anjard, C.; Loomis, W.F.; Subramani, S. Unconventional secretion of pichia 
pastoris Acb1 is dependent on grasp protein, peroxisomal functions, and autophagosome 
formation. J. Cell Biol. 2010, 188, 537–546. 
37.  Wong, J.; Zhang, J.; Si, X.; Gao, G.; Mao, I.; McManus, B.M.; Luo, H. Autophagosome supports 
coxsackievirus B3 replication in host cells. J. Virol. 2008, 82, 9143–9153. Viruses 2011, 3 
 
1561
38.  Talloczy, Z.; Jiang, W.; Virgin, H.W.,4th; Leib, D.A.; Scheuner, D.; Kaufman, R.J.; Eskelinen, 
E.L.; Levine, B. Regulation of starvation- and virus-induced autophagy by the eIF2alpha kinase 
signaling pathway. Proc. Natl. Acad. Sci. U. S. A. 2002, 99, 190–195. 
39.  Kemball, C.C.; Alirezaei, M.; Flynn, C.T.; Wood, M.R.; Harkins, S.; Kiosses, W.B.; Whitton, J.L. 
Coxsackievirus infection induces autophagy-like vesicles and megaphagosomes in pancreatic 
acinar cells in vivo. J. Virol. 2010, 84, 12110–12124. 
40. Yoon, S.Y.; Ha, Y.E.; Choi, J.E.; Ahn, J.; Lee, H.; Kweon, H.S.; Lee, J.Y.; Kim, D.H. 
Coxsackievirus B4 uses autophagy for replication after calpain activation in rat primary neurons. 
J. Virol. 2008, 82, 11976–11978. 
41.  Brabec-Zaruba, M.; Berka, U.; Blaas, D.; Fuchs, R. Induction of autophagy does not affect human 
rhinovirus type 2 production. J. Virol. 2007, 81, 10815–10817. 
42. Klein, K.A.; Jackson, W.T. Human rhinovirus 2 induces the autophagic pathway and replicates 
more efficiently in autophagic cells. J. Virol 2011, 85, 9651–9654. 
43.  Huang, S.C.; Chang, C.L.; Wang, P.S.; Tsai, Y.; Liu, H.S. Enterovirus 71-induced autophagy 
detected in vitro and in vivo promotes viral replication. J. Med. Virol. 2009, 81, 1241–1252. 
44.  O'Donnell, V.; Pacheco, J.M.; LaRocco, M.; Burrage, T.; Jackson, W.; Rodriguez, L.L.; Borca, 
M.V.; Baxt, B. Foot-and-mouth disease virus utilizes an autophagic pathway during viral 
replication. Virology 2011, 410, 142–150. 
45.    Zhang, Y.; Li, Z.; Xinna, G.; Xin, G.; Yang, H. Autophagy promotes the replication of 
encephalomyocarditis virus in host cells. Autophagy 2011, 7, 613–628. 
46.   Doedens, J.R.; Giddings, T.H., Jr; Kirkegaard, K. Inhibition of endoplasmic reticulum-to-golgi 
traffic by poliovirus protein 3A: Genetic and ultrastructural analysis. J. Virol. 1997, 71, 9054–9064. 
47.   Cho, M.W.; Teterina, N.; Egger, D.; Bienz, K.; Ehrenfeld, E. Membrane rearrangement and 
vesicle induction by recombinant poliovirus 2C and 2BC in human cells. Virology 1994, 202, 
129–145. 
48.  Barton, D.J.; Flanegan, J.B. Synchronous replication of poliovirus RNA: Initiation of negative-
strand RNA synthesis requires the guanidine-inhibited activity of protein 2C. J. Virol. 1997, 71, 
8482–8489. 
49.   Taylor, M.P.; Kirkegaard, K. Modification of cellular autophagy protein LC3 by poliovirus. 
J. Virol. 2007, 81, 12543–12553. 
50.  Moffat, K.; Knox, C.; Howell, G.; Clark, S.J.; Yang, H.; Belsham, G.J.; Ryan, M.; Wileman, T. 
Inhibition of the secretory pathway by foot-and-mouth disease virus 2BC protein is reproduced by 
coexpression of 2B with 2C, and the site of inhibition is determined by the subcellular location of 
2C. J. Virol. 2007, 81, 1129–1139. 
© 2011 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article 
distributed under the terms and conditions of the Creative Commons Attribution license 
(http://creativecommons.org/licenses/by/3.0/). 